Cetrorelix Acetate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Cetrorelix Acetate is used to treat ovarian hyperstimulation syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 11, 2000, and the first generic was approved Aug 12, 2022.
Cetrorelix Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $306.06 to $306.06 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$306.06 – $306.06
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing CETRORELIX ACETATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CETROTIDE 0.25 MG VIAL | $306.0574 per EA | — |
Frequently Asked Questions
What is Cetrorelix Acetate used to treat?
Cetrorelix Acetate is used to treat ovarian hyperstimulation syndrome, per the National Library of Medicine's MED-RT classification.
When did Cetrorelix Acetate become available as a generic?
FDA approved the first generic Cetrorelix Acetate (ANDA) on Aug 12, 2022.
How many Cetrorelix Acetate products are on the market?
The Cetrorelix Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Cetrorelix Acetate?
NADAC reference prices for Cetrorelix Acetate range from $306.0574 to $306.0574 per EA.
Which manufacturers make Cetrorelix Acetate?
1 manufacturer lists Cetrorelix Acetate in NADAC. Ranked by number of NDCs, the largest are EMD Serono, Inc. (1).